DNLI
Price
$16.51
Change
+$0.10 (+0.61%)
Updated
Dec 31 closing price
Capitalization
2.58B
59 days until earnings call
Intraday BUY SELL Signals
ONTTF
Price
$1.72
Change
-$0.02 (-1.15%)
Updated
Dec 31 closing price
Capitalization
1.67B
Intraday BUY SELL Signals
Interact to see
Advertisement

DNLI vs ONTTF

Header iconDNLI vs ONTTF Comparison
Open Charts DNLI vs ONTTFBanner chart's image
Denali Therapeutics
Price$16.51
Change+$0.10 (+0.61%)
Volume$1.16M
Capitalization2.58B
Oxford Nanopore Technologies
Price$1.72
Change-$0.02 (-1.15%)
Volume$14.6K
Capitalization1.67B
DNLI vs ONTTF Comparison Chart in %
DNLI
Daily Signal:
Gain/Loss:
ONTTF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DNLI vs. ONTTF commentary
Jan 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and ONTTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 02, 2026
Stock price -- (DNLI: $16.51 vs. ONTTF: $1.72)
Brand notoriety: DNLI and ONTTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 75% vs. ONTTF: 44%
Market capitalization -- DNLI: $2.58B vs. ONTTF: $1.67B
DNLI [@Biotechnology] is valued at $2.58B. ONTTF’s [@Biotechnology] market capitalization is $1.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $115.03B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileONTTF’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • ONTTF’s FA Score: 1 green, 4 red.
According to our system of comparison, ONTTF is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 3 TA indicator(s) are bullish while ONTTF’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 3 bullish, 6 bearish.
  • ONTTF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ONTTF is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -2.83% price change this week, while ONTTF (@Biotechnology) price change was -3.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.45%. For the same industry, the average monthly price growth was -0.05%, and the average quarterly price growth was +48.54%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-2.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.58B) has a higher market cap than ONTTF($1.67B). DNLI (0.000) and ONTTF (0.000) have similar YTD gains . ONTTF has higher annual earnings (EBITDA): -88.11M vs. DNLI (-534.17M). DNLI has more cash in the bank: 848M vs. ONTTF (332M). ONTTF (44.1M) and DNLI (44.4M) have identical debt. ONTTF has higher revenues than DNLI: ONTTF (205M) vs DNLI (0).
DNLIONTTFDNLI / ONTTF
Capitalization2.58B1.67B155%
EBITDA-534.17M-88.11M606%
Gain YTD0.0000.000-
P/E RatioN/AN/A-
Revenue0205M-
Total Cash848M332M255%
Total Debt44.4M44.1M101%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIONTTF
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 16 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signal:
Gain/Loss:
ONTTF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
COSOX12.52-0.03
-0.24%
Columbia Overseas Core Institutional 3
HMSIX12.23-0.03
-0.24%
Hennessy Midstream Institutional
COICX17.84-0.07
-0.39%
Calvert International Opportunities C
RGLJX28.33-0.15
-0.53%
American Funds Global Insight R-5E
PNSAX79.76-0.62
-0.77%
Putnam Small Cap Growth A

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with RGNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+0.61%
RGNX - DNLI
53%
Loosely correlated
+2.20%
XENE - DNLI
52%
Loosely correlated
+1.59%
BEAM - DNLI
52%
Loosely correlated
-0.36%
AVBP - DNLI
52%
Loosely correlated
-2.90%
NRIX - DNLI
52%
Loosely correlated
-0.26%
More

ONTTF and

Correlation & Price change

A.I.dvisor tells us that ONTTF and DNLI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONTTF and DNLI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONTTF
1D Price
Change %
ONTTF100%
-1.15%
DNLI - ONTTF
30%
Poorly correlated
+0.61%
QSI - ONTTF
27%
Poorly correlated
-0.90%
ALEC - ONTTF
26%
Poorly correlated
+2.63%
ADPT - ONTTF
26%
Poorly correlated
-1.10%
TECH - ONTTF
25%
Poorly correlated
-0.52%
More